Search Results
Mar 05, 2026, 08:00 ET RBL LLC Announces Launch of SteerBio with an up to $18.2 Million Federal Award to Pioneer a Curative Therapy for Lymphedema
alongside Veiseh, who is scientific co-founder, and clinical collaborators Edward Chang, MD, professor in the Department of Plastic Surgery at The University of Texas MD Anderson Cancer Center and Ionela Iacobas, MD, Medical Director of the Vascular Anomalies Center and at Texas Children's Hospital/Baylor
More news about: RBL LLC
Mar 05, 2026, 08:00 ET Mitria Medical Announces First Use of Novel Mitral Valve Repair Device in U.S. Under Single Patient Expanded Access
functional mitral regurgitation," said Jose Navia, MD, Vice Chief, Heart, Vascular & Thoracic Institute, Cleveland Clinic Florida."Continued innovation is essential due to the complex morphology of mitral valve disease," said Samir Kapadia, MD, Chair, Department of Cardiovascular Medicine,
More news about: Mitria Medical, Inc.
Mar 05, 2026, 08:00 ET SimBioSys Highlights Clinical Data Demonstrating AI Digital Twin Performance Comparable to Radiologists at 43rd Annual Miami Breast Cancer Conference®
reliably mirror radiologist assessments have the potential to improve clarity, reproducibility, and communication across care teams," added Barry Rosen, MD, FACS, Breast Surgical Oncologist and Chief Medical Officer of SimBioSys.This study adds to a growing portfolio of clinical evidence supporting
More news about: SimBioSys
Mar 05, 2026, 08:00 ET Revalesio to Present Advances in Stroke Treatment with RNS60 at the American Society for Experimental Neurotherapeutics (ASENT) Annual Meeting
American Society for Experimental Neurotherapeutics (ASENT) Annual Meeting on March 5 in Bethesda, MD. Revalesio will contribute to two scientific sessions focused on reinvigorating the stroke therapeutic landscape and advancing the neurotherapeutics pipeline.
More news about: Revalesio Corporation
Mar 05, 2026, 07:05 ET REGENXBIO Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
potential path forward for RGX-121Conference call today at 8:00 a.m. ETROCKVILLE, Md., March 5, 2026 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today reported financial results and operational
More news about: REGENXBIO Inc.
Mar 05, 2026, 07:00 ET Hemab Therapeutics Receives FDA Breakthrough Therapy Designation for Sutacimig in Glanzmann Thrombasthenia
urgency of bringing new treatment options to people living with Glanzmann thrombasthenia who have been historically underserved," said Benny Sorensen, MD, PhD, Chief Executive Officer of Hemab. "We look forward to continued collaboration with the FDA, with the goal of bringing the first prophylactic treatment
More news about: Hemab Therapeutics
Mar 05, 2026, 07:00 ET NexCure, Inc. Launches with $19 Million Series A Financing to enable CAR-T and other advanced treatment delivery in community outpatient settings
only a fraction of patients who are eligible for CAR-T therapy actually receive it, largely due to where and how care is delivered," said Paul Rothman, MD, Venture Partner at Raven, RA Capital's healthcare incubator, and Founder and Board Chair of NexCure. "As CAR-T matures and moves beyond oncology into
More news about: NexCure Inc.
Mar 05, 2026, 06:30 ET Spin Master Reports Q4 2025 Financial Results
today announced its financial results for the three months and year ended December 31, 2025. The Company's full Management's Discussion and Analysis ("MD&A") for the three months and year ended December 31, 2025 is available under the Company's profile on SEDAR+ (
More news about: Spin Master Corp.
Mar 05, 2026, 06:07 ET PedidosYa reafirma su compromiso con la equidad y el desarrollo del talento femenino en Latam
https://mma.prnewswire.com/media/2922268/Patricia_Gonz_lez__MD_de_PedidosYa_Panam__y_Paola_Sevilla__MD_de_PedidosYa_Guate.jpg
More news about: PedidosYa
Mar 05, 2026, 06:00 ET Pivot Energy and Sustain Our Future Foundation Partner to Invest $400,000 in Communities in Garrett County, MD, Kicking Off Multi-Year Commitment
first round of grants, totaling $400,000, was released to the following local community non-profits and local social enterprises in Garrett County, MD:
More news about: Pivot Energy
Mar 05, 2026, 06:00 ET Inventory Recovery is Plateauing: Realtor.com® February Monthly Housing Report
-0.2Baltimore-Columbia-Towson, MD16.5 %
More news about: Realtor.com
Mar 05, 2026, 06:00 ET Maple Leaf Foods Reports Fourth Quarter and Full Year 2025 Financial Results
expressed or implied by the forward-looking statements herein, including, without limitation, the factors found under the heading "Risk Factors" in this MD&A. The reader should review such section in detail. Additional information concerning the Company, including the Company's Annual Information Form for
More news about: Maple Leaf Foods Inc.
Mar 05, 2026, 02:24 ET New Publication: US clinicians' real-world Nevisense experience improves melanoma detection
Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, announced that Stephen D. Hess, MD, PhD, FAAD, has published a clinical article highlighting his real-world experience integrating Nevisense into routine melanoma detection. The article
More news about: SciBase
Mar 04, 2026, 21:01 ET Empowering the SBMA Community: AnnJi Highlights Patient & Family Forum and Shares AJ201 Scientific Advancement at the 2026 KDA Conference
and aims to further validate AJ201's therapeutic benefit in this underserved patient population.Additionally, Dr. Christopher Grunseich, MD, the study's Principal Investigator, led a featured session titled "Safety and Preliminary Efficacy Demonstrated in a Phase 1/2a Clinical Trial of
More news about: AnnJi Pharmaceutical Co., Ltd.
Mar 04, 2026, 20:31 ET Empowering the SBMA Community: AnnJi Highlights Patient & Family Forum and Shares AJ201 Scientific Advancement at the 2026 KDA Conference
and aims to further validate AJ201's therapeutic benefit in this underserved patient population.Additionally, Dr. Christopher Grunseich, MD, the study's Principal Investigator, led a featured session titled "Safety and Preliminary Efficacy Demonstrated in a Phase 1/2a Clinical Trial of
More news about: AnnJi Pharmaceutical Co., Ltd.
Mar 04, 2026, 17:43 ET Study: Football associated with nearly one in five brain injuries in youth sports
are a common, yet preventable, source of long-term neurological and psychiatric issues in children and young adults," said study author Steven Wolf, MD, of Boston Children's Health Physicians in Hawthorne, New York, and member of the American Academy of Neurology. "Our study found that nearly one in five
More news about: American Academy of Neurology
Mar 04, 2026, 16:14 ET FIRST UNITED CORPORATION ANNOUNCES SECOND QUARTER 2026 DIVIDEND
OAKLAND, Md., March 4, 2026 /PRNewswire/ -- First United Corporation (NASDAQ: FUNC) announces that its Board of Directors declared a cash dividend of $.26 per share that will be payable on May 1, 2026, to holders of record
More news about: First United Corporation
Mar 04, 2026, 15:30 ET "HEALING HEROES NO MIND LEFT BEHIND" ANNOUNCES WORLD PREMIERE IN DALLAS ON MARCH 25
documentary stands as a testament to hope, resilience, and the human capacity to heal.About Charles "Dr. Charlie" Powell, MDCharles "Dr. Charlie" Powell, MD is a physician, healthcare entrepreneur, and former Naval Lieutenant Commander with more than 30 years of experience spanning clinical
More news about: Solo Vive™
Mar 04, 2026, 13:40 ET American Academy of Orthopaedic Surgeons Announces Elizabeth G. Matzkin, MD, FAAOS, as Second Vice President
NEW ORLEANS , March 4, 2026 /PRNewswire/ -- Boston orthopaedic surgeon Elizabeth G. Matzkin, MD, FAAOS, has been named second vice president of the American Academy of Orthopaedic Surgeons (AAOS) following the AAOS 2026 Annual Meeting in New Orleans.
More news about: American Academy of Orthopaedic Surgeons
Mar 04, 2026, 13:35 ET American Academy of Orthopaedic Surgeons Announces Michael L. Parks, MD, FAAOS, as First Vice President
NEW ORLEANS, March 4, 2026 /PRNewswire/ -- New York orthopaedic surgeon Michael L. Parks, MD, FAAOS, has been named first vice president of the American Academy of Orthopaedic Surgeons (AAOS). His appointment marks the second year of a four-year
More news about: American Academy of Orthopaedic Surgeons
Mar 04, 2026, 13:34 ET $425 Million Settlement Reached in Capital One 360 Savings Account Interest Rate Litigation
that, if approved by the Court, would resolve the lawsuit titled In re: Capital One 360 Savings Account Interest Rate Litigation, No. 1:24-md-03111-DJN (E.D. Va.). The Defendants, Capital One, N.A. and Capital One Financial Corporation (collectively "Capital One" or "Defendants") deny any wrongdoing, and the Court
More news about: United States District Court for the Eastern District of Virginia
Mar 04, 2026, 13:30 ET Wilford K. Gibson, MD, FAAOS, Named 94th President of the American Academy of Orthopaedic Surgeons
March 4, 2026 /PRNewswire/ -- The American Academy of Orthopaedic Surgeons (AAOS) announced Virginia orthopaedic surgeon Wilford K. Gibson, MD, FAAOS, as its new president. Dr. Gibson will assume the position following the AAOS 2026 Annual Meeting in New Orleans. The new role marks Dr. Gibson's
More news about: American Academy of Orthopaedic Surgeons
Mar 04, 2026, 13:00 ET Rice-led research to develop first regenerative therapy for lymphedema receives up to $18.2M federal award
alongside Veiseh, who is scientific co-founder, and clinical collaborators Edward Chang, MD, professor in the Department of Plastic Surgery at The University of Texas MD Anderson Cancer Center and Ionela Iacobas, MD, Medical Director of the Vascular Anomalies Center and director of the Vascular Anomalies
More news about: Rice University
Mar 04, 2026, 11:31 ET CMS Administrator Dr. Mehmet Oz and Mayo Clinic Platform President Dr. John D. Halamka Join HIMSS26 Keynote Lineup
Mehmet Oz, the 17th Administrator of the nation's largest healthcare agency (Centers for Medicare & Medicaid Services) and John D. Halamka, MD, MS, President of the
More news about: Informa Connect
Mar 04, 2026, 10:50 ET Kelsey H. Collins, PhD, Wins NEXT Award for Translational Research on Relationship between Fat and Osteoarthritis Development and Pain
Herzog, and other key opinion leaders in the field, like committee member Cyril Frank, MD, led an interdisciplinary initiative to try to develop new solutions for OA. In one of these team meetings, Gillian Hawker, MD, FRCPC, shared that we were all missing a key target population – the role of obesity
More news about: American Academy of Orthopaedic Surgeons